Although 52% of healthcare leaders believe a fatal cyber-related patient incident will happen within the next five years, cybersecurity was not ranked as a top business challenge, according to the results of Omega Systems’ 2025 Healthcare IT Landscape Report.
Concerns over healthcare IT safety are growing in the United States, and with good reason—80% of healthcare organizations were targeted at least once within the past year, according to the results of Omega Systems’ 2025 Healthcare IT Landscape Report.
However, the report also shows that overall, as a top business challenge, cybersecurity ranked last (33%) behind rising operational costs (53%) and maintaining compliance (52%).
“Healthcare is one of the most frequently targeted industries by cybercriminals—and not surprisingly, given the sensitive data they manage,” Mike Fuhrman, CEO of Omega Systems, said in the news release. “Unfortunately, growing gaps in cyber risk management are resulting in real-world consequences for patients and major setbacks for organizations. This disconnect is a growing risk across the healthcare industry that needs to be addressed with better visibility, readiness and resources.”
Survey results are based on the opinions of 250 healthcare business leaders in the United States, including CEOs, CIOs and COOs, who completed Omega Systems’ online survey in April 2025. Medical care practices and clinics, ambulatory care centers and medical billing companies were some of the organizations surveyed. The size of each organization varied between 50 and 500 employees.
Social engineering attacks, like phishing (48%) and ransomware (34%), were the most common methods used by cybercriminals.
Scroll through the slideshow above to read the rest of the highlights.
Get the latest industry news, event updates, and more from Managed healthcare Executive.
A Conversation with Jeremiah Johnson, Executive Director of PrEP4All
July 25th 2025Jeremiah Johnson, executive director of PrEP4All, an organization committed to HIV prevention and care, talks about the importance of preexposure anaphylaxis and why he’s hesitant to jump on the Lenacapavir breakthrough bandwagon.
Read More
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Accepts Tabelecleucel BLA; Priority Review Granted for Post-Transplant Disease Therapy
July 24th 2025The FDA has accepted the resubmitted BLA for tabelecleucel (tab-cel), intended for the treatment of Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Read More